Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Cash from Financing Activities (2018 - 2026)

OptimizeRx's Cash from Financing Activities history spans 12 years, with the latest figure at -$3.4 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 22.1% to -$3.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$8.8 million, a 79.15% decrease, with the full-year FY2025 number at -$8.8 million, down 79.15% from a year prior.
  • Cash from Financing Activities hit -$3.4 million in Q4 2025 for OptimizeRx, down from -$258000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for OPRX hit a ceiling of $70.2 million in Q1 2021 and a floor of -$12.0 million in Q3 2022.
  • Historically, Cash from Financing Activities has averaged $3.5 million across 5 years, with a median of -$440000.0 in 2023.
  • Biggest five-year swings in Cash from Financing Activities: soared 62476.44% in 2021 and later crashed 3080.6% in 2023.
  • Tracing OPRX's Cash from Financing Activities over 5 years: stood at $1.1 million in 2021, then tumbled by 802.65% to -$7.4 million in 2022, then surged by 586.46% to $36.2 million in 2023, then tumbled by 107.8% to -$2.8 million in 2024, then decreased by 22.1% to -$3.4 million in 2025.
  • Business Quant data shows Cash from Financing Activities for OPRX at -$3.4 million in Q4 2025, -$258000.0 in Q3 2025, and -$4.5 million in Q2 2025.